Why we’re focused on promotional marketing at health systems
Six weeks into ServingOverSelling and the response has been positive. I’ve heard from many people both online and in conversations that they support the effort and a number have signed our public pledge. On the other hand, while I haven’t heard directly from those who don’t understand or oppose the movement, I’m told the campaign has ruffled a few feathers. That was expected, of course. It’s hard to call out a popular industry practice without those who are invested in that practice feeling at best confused, and at worst antagonistic to the effort. Perhaps the top question I get from those I’ve talked to is along the lines of “Why focus on health system marketing given all of the problems in our U.S. healthcare system? You don’t believe promotional marketing at hospitals is really the cause of the affordability crisis, do you?”
No, in fact I don’t. At least not the biggest cause. As I wrote at launch in My Jerry Maguire Letter to the Industry, it took a lot of intersecting dynamics for me to land on ServingOverSelling, and as I’ve written, promotional marketing is not even the biggest problem within the health system space, let alone the entire $5 trillion healthcare industry. From where I sit, here are the primary black hats when it comes to the healthcare affordability crisis:
Health insurance – If the purpose of health insurance companies is to help control costs in the industry, they have failed spectacularly. Worse, the for-profit insurers are driven solely by shareholder value, not contributing to or improving healthcare, but instead focusing only on profits (if improving healthcare can make them money, well then, sure, they’ll pursue that). In 2025, for example, UnitedHealth Group had $12.1 billion in profits, Cigna $6 billion and Elevance $5.7 billion. Put aside their integrated offerings and focus on the insurance (United is the largest employer of physicians in the country), and their business model as insurers is to make money from denying healthcare. It really is that simple.
Pharma – Drug prices in the U.S. average 2.78 times those in 33 other countries in a study from RAND, and 4.22 times for brand-name drugs. While the U.S. represents 24% of drug volumes internationally, we account for 62% of the spending. Why do drug companies charge more in the U.S.? Because we let them.
Private Equity – No matter the exact model used, PE firms are focused on one thing and one thing only: making money. With the recent acquisitions of everything from physician practices to anesthesia groups to surgery centers to even health system ad agencies, the goal is to raise prices and make more profits. In just one example, anesthesia prices rose 25-30% within two years of a wave of PE acquisitions in that field. There is no net value to patients or the healthcare system from PE – only to those who profit.
Middlemen – The number of healthcare-specific sectors that profit from the delivery of care is in the dozens if not hundreds. Revenue cycle management, coding and billing, GPOs, brokers, PBMs, consultancies, ad agencies, IT firms – the list goes on and on (and on). In just two more recent – and egregious – examples: first, huge consultancies were awarded multimillion-dollar government contracts to manage new work eligibility rules for Medicaid (aka money was cut from people who need assistance for care and given to those who profit off the bureaucracy). And second: arbitration companies are driving up the cost of care by awarding huge sums to provider claimants in no-surprise billing cases in large part to incent those providers to submit more claims (which is how the arbitration companies make their money).
Providers – Of all the players in the U.S. healthcare system, hospitals, health systems and other providers join pharma and medtech as the only truly essential components in terms of care delivery. Without hospitals, clinics, doctors, nurses, etc., there is no healthcare. But while their role is essential, health systems still contribute to the affordability crisis in healthcare in many ways: billion-dollar facilities, high levels of administrative costs, questionable executive and physician pay, and for the nonprofit organizations, all while receiving local, state and federal tax exemptions.
All of these players contribute far more to the healthcare affordability crisis than the promotional marketing spend at hospitals and health systems contributes. Far, far more. So then why focus on trying to curb the practice of promotional marketing at health systems? Why not focus on these other issues? The answers from where I sit are straighforward:
First, I have come to believe that the vast majority of promotional marketing for health systems is ineffective and/or a giant waste of money. If it doesn’t work, why continue to do it?
Second, just because the spend on health system promotional marketing is a drop in the bucket (likely $3-5 billion as part of the total $5 trillion spent on healthcare annually) doesn’t mean it’s ok to continue the spend. Every dollar health systems spend makes a difference, so if that spend can go to serving patients and communities rather than being wasted on self-promotion, that’s low hanging fruit in terms of the affordability crisis.\
Third, I had to make an important calculation on the impact I could have. Sure, I could go after health insurers, but I would be one voice in 10,000, with 9,999 others having far more credibility and reach than I ever could muster. But I know the health system marketing space – I know how it works, I know the power dynamics, and I know the people. With more than 25 years of experience in this space, I know what works and what doesn’t. And I’d like to think I have some credibility in this space. The hope is that through ServingOverSelling, the bigger splash I can make in a smaller pond will have an overall bigger impact at the end of the day.
So while there are far larger black hats when it comes to the affordability crisis in American healthcare, promotional marketing for health systems is still an issue that needs to be addressed. There are far better ways for health systems - and their marketing leaders - to spend that money. And that’s what ServingOverSelling is all about.